Stock RKV RAKOVINA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Rakovina Therapeutics Inc.

Equities

RKV

CA75103L1013

Delayed Toronto S.E.
Other stock markets
 17:01:05 30/04/2024 BST 		5-day change 1st Jan Change
0.09 CAD +5.88% Intraday chart for Rakovina Therapeutics Inc. +5.88% +5.88%
04-09 Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting MT
2023 Rakovina Therapeutics Announces Appointment to Scientific Advisory Board MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
AQ
Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update
GL
Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting
MT
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
GL
Accelerating New Molecule Discovery: Rakovina Therapeutics AI Integration
AQ
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
GL
Rakovina Therapeutics Announces Strategic Pivot to AI
GL
Rakovina Therapeutics Inc. Announces Q3 2023 Financial Results and Provides Corporate Update
GL
Rakovina Therapeutics Announces Appointment to Scientific Advisory Board
MT
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board
GL
Rakovina Therapeutics Welcomes Prof. Artem Cherkasov to the Company’s Scientific Advisory Board
AQ
Rakovina Therapeutics Appoints Prof. Artem Cherkasov to the Scientific Advisory Board
CI
Rakovina Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
GL
Rakovina Therapeutics Inc. Announces Appointment of Prof. Petra Hamerlik as New Scientific Advisory Board Member
CI
Rakovina Therapeutics continues to make progress as company provides corporate update
AQ
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
GL
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
AQ
Rakovina Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Rakovina Therapeutics Announces Results from 2023 Annual General Meeting
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RKV Stock
  4. News Rakovina Therapeutics Inc.